Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer

Citation
N. Haruki et al., Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer, CANCER RES, 60(17), 2000, pp. 4689-4692
Citations number
21
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
60
Issue
17
Year of publication
2000
Pages
4689 - 4692
Database
ISI
SICI code
0008-5472(20000901)60:17<4689:HTTEOA>2.0.ZU;2-F
Abstract
Inactivation of p53, which represents the most prevalent genetic alteration in lung cancer, has been shown to play a crucial role in the acquisition o f genomic instability. We examined 44 lung cancer specimens to search for m utations in the CHK1 and CHK2 genes, which have been suggested to play role s in regulating p53 after DNA damage. We found that the CHK2 gene was somat ically mutated in lung cancer in vivo, although at a Low frequency, and tha t a previously undescribed shorter isoform of CHK1 was expressed preferenti ally in small cell lung cancer in a tumor-predominant manner. Additional st udies are warranted to investigate the functional significance of these cha nges as well as the potential involvement of other components in this impor tant pathway to maintain genomic stability.